Rare essentials: drugs for rare diseases as essential medicines
Bulletin of the World Health Organization, 2006 Since 1977, the WHO Model List of Essential Medicines (EML), published by WHO, has provided advice for Member States that struggle to decide which pharmaceutical technologies should be provided to patients within their public health systems.
Pieter Stolk +2 more
doaj +6 more sources
Survey and analysis of the availability and affordability of essential drugs in Hefei based on WHO / HAI standard survey methods [PDF]
BMC Public Health, 2020 Background The 2018 edition of the National Essential drugs List came into effect in September 2018. Relevant policies require that all primary medical and health institutions should supply national essential drugs, while secondary and tertiary medical ...
Zuojun Dong, Qiucheng Tao, Guojun Sun
doaj +2 more sources
Digital transformation, green finance, and pharmaceutical affordability in China: a health economics perspective [PDF]
Frontiers in Public HealthIntroductionDrug accessibility is a core challenge facing global public health systems, with financing costs directly affecting drug prices through cost-plus pricing mechanisms.
Jingdong Huang, Xinyi Zhang
doaj +2 more sources
Annals of Medicine, 1993 Availability of an appropriate selection and regular supply of affordable drugs that are efficacious, safe and of good quality, is a prerequisite for any operative health care system. In most of the industrialized countries a variety of drugs are usually available in sufficient quantity and some drugs may even be over-used in medical therapy, yet half ...
exaly +3 more sources
Evaluating the availability of essential drugs for hypertension, diabetes and asthma in rural Rwanda, 2018. [PDF]
Public Health Action, 2021 Mbonyinshuti F +7 more
europepmc +2 more sources
Effectiveness and safety of oral Chinese patent medicines as adjuvant treatment for unstable angina pectoris on the national essential drugs list of China: a protocol for a systematic review and network meta-analysis. [PDF]
BMJ Open, 2019 Hua Z +10 more
europepmc +3 more sources
Study on the Relationship Between the Number of Adverse Drug Reactions of Essential Drugs and Visits: Based on Vector Autoregressive Model. [PDF]
Risk Manag Healthc Policy, 2023 Tang W, Chen H, Zhang Z, Wu G, Lin Y.
europepmc +2 more sources
Are drugs for rare diseases "essential"?
Bulletin of the World Health Organization, 2006 In 1977, the first report of the WHO Expert Committee on the Use of Essential Drugs defined essential drugs as those needed to satisfy the health-care needs of the majority of the population. This was done in order to fulfil a mandate to assist Member States in selecting and obtaining essential medicaments for their populations.
Marcus M Reidenberg
doaj +3 more sources
The evidence-informed decision-making process of the National Essential Medicines List Committee and Essential Drugs Programme [PDF]
Journal of the Colleges of Medicine of South AfricaAmanda Brewer +7 more
doaj +2 more sources
A third-line antiretroviral therapy register to track patient clinical and virological outcomes
South African Medical Journal, 2022 -
K Naidoo +3 more
doaj +1 more source